Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease**This study was supported by Bristol-Myers Squibb, Plainsboro, New Jersey.
Authors:
- Joel W. HayJHJoel W. Hay
- Bertram PittBPBertram Pitt
- Ellison WittelsEWEllison Wittels
- John CrouseJCJohn Crouse
- Michael DavidsonMDMichael Davidson
- Curt D. FurbergCFCurt D. Furberg
- Larry RadicanLRLarry Radican
- 1 August 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (4) , 409-414
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of posthospital survival after acute myocardial infarction in women and menThe American Journal of Cardiology, 1994
- Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)The American Journal of Cardiology, 1993
- A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.Circulation, 1993
- A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United StatesNew England Journal of Medicine, 1993
- Pravastatin, lipids, and atherosclerosis in the carotid arteries: Design features of a clinical trial with carotid atherosclerosis outcomeControlled Clinical Trials, 1992
- Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysisJACC, 1991
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- Prognosis after myocardial infarction: results of 15 year follow up.BMJ, 1984
- Long survival following myocardial infarctionThe American Journal of Cardiology, 1962